Latest News and Press Releases
Want to stay updated on the latest news?
-
PARIS, July 04, 2025 (GLOBE NEWSWIRE) -- (Article 223-16 of General Regulation of the French financial markets authority) Listing market: Euronext Growth ISIN code: FR0010425595 DateTotal number...
-
杭州,开罗, June 27, 2025 (GLOBE NEWSWIRE) -- EVA制药公司,中东和非洲地区增长最快的医疗保健组织之一,与杭州美丽云城管理办公室(Chaming Qiantang Management Office)签署了一项合作协议,以加强其全球战略扩展,并致力于在中国的创新、本地化和全球合作。 ...
-
HANGZHOU, China and CAIRO, June 26, 2025 (GLOBE NEWSWIRE) -- EVA Pharma, one of the leading pharmaceutical companies driving healthcare innovation and access across the Middle East and Africa, has...
-
Labviva showcases advanced AI procurement tools at the R&D Procurement and Sourcing in Pharma Summit 2025.
-
Labviva, the AI-powered life sciences procurement leader, announces key executive appointments to drive global expansion and accelerate growth.
-
NodThera Announces Appointment of Elisabeth Björk as Board Member Former SVP at AstraZeneca R&D brings deep expertise in obesity and cardiometabolic research, portfolio strategy development and...
-
NEW YORK, June 16, 2025 (GLOBE NEWSWIRE) -- Yseop, the global leader in Generative AI for life sciences, today announced the next phase in delivering its One-Click Dossier vision, a scalable...
-
CHASKA, Minn., June 12, 2025 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR) (“Lifecore”), a fully integrated contract development and manufacturing organization (“CDMO”), today...
-
On June 9th, PolyPid Ltd.* announced landmark topline results from its pivotal SHIELD II Phase 3 trial, demonstrating that D-PLEX100 achieved statistically significant reductions across all primary...
-
On June 9th, PolyPid Ltd.* announced landmark topline results from its pivotal SHIELD II Phase 3 trial, demonstrating that D-PLEX100 achieved statistically significant reductions across all primary...